噻托溴铵奥达特罗能倍乐在中国的价格

It is a classic drug for the treatment of stable COPD. On this basis, Boehringer Ingelheim has specially developed a new inhaled long-acting β2 receptor agonist olodaterol.

Tiotropium bromide, olodaterol and Respimat are new drugs developed by Boehringer Ingelheim. They have been officially approved by the China Food and Drug Administration and are suitable for long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD, referred to as COPD, including chronic bronchitis and emphysema) to relieve symptoms.

As a common respiratory disease, COPD has high morbidity and mortality rates and is very harmful. Everyone needs early treatment to prevent complications. In daily life, you should quit smoking, prevent colds and engage in regular physical exercise. The diet should be light, eat more fruits and vegetables, and eat small meals frequently.

According to clinical trial data, the therapeutic effect of tiotropium bromide, olodaterol, and repimat is significant. The successful development of this drug is good news for many patients. However, patients cannot blindly take this drug for treatment. Before receiving treatment with tiotropium bromide, olodaterol, and repimat, patients should go to the hospital for a detailed examination and strictly follow the doctor's diagnosis and treatment recommendations. During the treatment period, patients should not increase or decrease the dosage of drugs without authorization. Only correct use of drugs will help the condition.

It is understood that tiotropium bromide, olodaterol, and repimat are already on the market in China, so patients can purchase the drug at major domestic regular pharmacies or hospital pharmacies with a prescription issued by a doctor. Tiotropium bromide and olodaterol Respimat have been included in Category B of medical insurance. However, due to differences in drug specifications and local medical insurance reimbursement standards, accurate drug prices cannot be provided. Patients can go to the local hospital pharmacy for consultation.

According to Medical Companion Travel, the most cost-effective product is about $170 per box. Since the exchange rate floating price is not fixed, if patients want to know the specific price information of the drug, they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/83760.html